SANG Stock Jumps As BRC Group Buyout Locks In Big Premium

Sangoma Technologies Corporation’s stocks have been trading up by 39.28 percent following upbeat sentiment around its strategic growth prospects.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading SANG

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Sangoma Technologies agreed to be acquired by BRC Group Holdings for about US$5.225 per share, a 47–51% premium to recent TSX trading, with closing targeted by early 2027 pending multiple approvals.
Under the deal, Sangoma shareholders get US$4.925 in cash plus 0.04767 BRC (RILY) shares per SANG share, valuing the company near $204M enterprise value, with SANG to be delisted after closing.
Recent Q4 for Sangoma showed modest revenue growth and solid recurring-service and margin profile, but a large net loss tied to goodwill impairment and an inventory write-down.
The company fixed an ERP-related revenue overstatement that did not hit cash, and suspended forward guidance and its earnings call as it focuses on the sale process.
Sangoma also reported a much larger-than-expected Q4 loss and revenue below estimates, announced alongside board approval of the definitive sale agreement.

Live Update At 09:17:46 EDT: On Tuesday, September 29, 2026 Sangoma Technologies Corporation stock [NASDAQ: SANG] is trending up by 39.28%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

For active traders, SANG has basically shifted from a pure growth story to a merger-arbitrage setup overnight. The chart tells the story. SANG spent most of September grinding between roughly $3.44 and $3.82, with the last full daily close at $3.59 on 2026/09/28. That’s well below the implied US$5.225 takeout value, which explains why the intraday tape now shows heavy trading clustering right around $4.90–$5.00.

Fundamentally, Sangoma Technologies is a mixed bag. Revenue over the last year sits near $236.7M, but three-year revenue growth is negative at about -5.4%, showing a slowdown after earlier expansion. At the same time, SANG runs a very high gross margin around 71.2%, and EBITDA margin is a healthy 17.7%. The problem is below the line: net margins and return metrics are negative, with return on equity around -11.1% and return on assets in the red.

More Breaking News

On the balance sheet, Sangoma Technologies carries modest leverage. Total debt-to-equity is only 0.16 and interest coverage is comfortable at 13.9, but the current ratio at 0.9 shows limited short-term cushion. For traders, this backdrop helps explain why a $204M enterprise-value cash-and-stock bid surfaced here rather than at a higher growth multiple.

Why Traders Are Watching SANG After The Buyout News

SANG has turned into a textbook event-driven trade. Sangoma Technologies agreed to a sale to BRC Group Holdings at an implied US$5.225 per share, far above where SANG was drifting on the TSX just days ago. That 47–51% premium instantly reset the game. Instead of debating quarterly misses, traders now focus on the spread between the market price and the deal value, and on the odds that the deal actually closes.

The structure matters. Each Sangoma Technologies share will be swapped for US$4.925 in cash plus 0.04767 of a BRC (RILY) share, pegging enterprise value at about $204M. Post-closing, SANG is expected to be delisted, likely by early 2027 if shareholder, court, and regulatory approvals arrive on schedule. Until then, the stock trades as a proxy for that future payout, discounted for time and risk.

At the same time, the Q4 numbers out of SANG were rough on the surface. Sangoma Technologies posted a much larger-than-expected loss and year-over-year revenue that missed estimates. A big non-cash goodwill impairment and an inventory write-down drove the red ink, even as recurring services, margins, and cash generation stayed solid. Management also corrected an ERP-related revenue overstatement and then suspended guidance and its usual earnings call once the sale process went live.

For day traders and swing traders, that combination is key. Weak standalone fundamentals often cap upside. Here, the BRC Group bid effectively backstops Sangoma Technologies around the deal value, barring a breakdown in approvals. That’s why SANG’s intraday action is now hugging the high $4s instead of repricing down on the earnings miss. The chart has shifted from trend and momentum to a tight, news-sensitive range.

Conclusion

SANG is no longer a typical small-cap tech trade. Sangoma Technologies is now an event story tied to a $204M take-private deal with BRC Group Holdings. The market is weighing three things: the size of the premium, the long runway to an expected early-2027 close, and the usual closing risks around shareholder votes, courts, and regulators. Every headline on those fronts can jolt SANG inside what looks like a narrow arbitrage band.

Traders also know that Sangoma Technologies is not being bought from a position of pure strength. Q4 showed modest revenue growth but a large loss, driven by goodwill and inventory hits, and revenue trends that disappointed the Street. SANG still has strong recurring revenue and a fat gross margin, yet returns on capital remain negative. That mix likely shaped the final price BRC was willing to pay.

For active traders, the playbook is different now. The big trend move already happened on the announcement. From here, SANG becomes a spread, liquidity, and news-flow trade, not a long-term growth swing. As Tim Sykes pounds into students, “The market doesn’t owe you anything — react to what’s actually happening, not what you wish would happen.” As Tim Bohen, lead trainer with StocksToTrade says, “A consistent trading routine beats sporadic action every time. Show up daily, and you’ll start to see the patterns others miss.” That kind of disciplined, day-in, day-out focus is exactly what’s needed when you’re navigating a tight arbitrage band and headline-driven volatility. With Sangoma Technologies, what’s actually happening is a defined buyout path and a ticking clock, and that’s how serious traders should frame every decision around SANG going forward.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!